Skip to main content
. Author manuscript; available in PMC: 2013 Jul 17.
Published in final edited form as: Nat Rev Immunol. 2007 Jul 20;7(8):633–643. doi: 10.1038/nri2133

Table 1.

Comparison of anergic-B-cell phenotypes

Mouse
model
Antigen
specificity
Developmental
blockade
Lifespan Phenotype in basal
state
Outcomes of BCR aggregation
(IgM-specific antibody)
Outcomes of TLR
ligation
Refs
MD4×
ML5
HEL Yes, at T3 B-cell
stage
Short IgMlow, CD86low, high
intracellular Ca2+, high
ERK phosphorylation
  • Reduced Igα and Igβ Phosphorylation

  • Reduced SYK phosphorylation

  • No Ca2+ mobilization

  • No activation-marker expression

  • No proliferation

  • Normal proliferation

  • Normal antibody secretion*

  • Normal activation- marker expression

5,6,7,36
VH3H9×
Vλ2
dsDNA Yes, at immature
B-cell stage
Short IgMmid, CD80–, CD86–
,↑HSA, TCD44,
↑MHC class II
  • Reduced SYK phosphorylation

  • No activation-marker expression

  • No proliferation

  • No proliferation

  • No antibody secretion

12,13
VH3H9×
Vκ8
ssDNA No Normal Normal
  • Normal Ca2+ mobilization

  • Normal SYK phosphorylation

  • Intermediate proliferation

  • Intermediate Proliferation

  • No antibody secretion

12,14
VH125 ×
Vκ125
Insulin No Normal Normal
  • Normal signalling (Igα, Igβ and SYK phosphorylation, Ca2+ mobilization)

  • No proliferation

  • Normal activation-marker expression

  • No proliferation

  • No antibody secretion

26,61
VH2–12 ssDNA, Sm Yes, at pre-
plasma-cell
stage
Normal
or short
↑CD80, ↑CD40, ↑ CD44,
slight increase in ERK
phosphorylation
  • Normal SYK phosphorylation

  • Weak proliferation

  • Normal proliferation

  • Normal antibody secretion

21,22
VH2–12×
Vκ8
Sm No Normal ↑CD95, ↑MHC class II,
IgMmid
  • Normal SYK phosphorylation

  • No antibody secretion

24,53
Ars/A1 ssDNA Yes, at T3 B-cell
stage
Short
(in vitro)
IgMmid, CD80hi, CD95hi
MHC class IIhi, high
intracellular Ca2+, high
ERK phosphorylation
  • Reduced Igα and IgβPhosphorylation

  • Reduced SYK phosphorylation

  • No Ca2+ mobilization

  • No activation-marker expression

  • No proliferation

  • No antibody secretion

  • Normal proliferation

  • Normal antibody secretion*

  • Normal activation- marker expression

28,30
An1 Mixed Yes, at T3 B-cell
stage
Short ND
  • Reduced Ca2+ mobilization

  • No activation-marker expression

  • Normal antibody secretion

29
*

Evidence suggests that this only occurs if in vitro cultures are free of dendritic cells and macrophages53. BCR, B-cell receptor; dsDNA, double-stranded DNA; ERK, extracellular-signal-regulated kinase; HEL, hen-egg lysozyme; HSA, heat-stable antigen; ND, not determined; Sm, Smith antigen; ssDNA, single-stranded DNA; SYK, spleen tyrosine kinase; T3, transitional 3; TLR, Toll-like receptor.